The NEUF study: Treatment of r/r Philadelphia chromosome-positive ALL with blinatumomab
Published: 23 Jun 2020
Views: 631
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
Dr Josep Ribera speaks to ecancer in an online interview for the virtual EHA 2020 meeting.
He discusses the NEUF study which looks at the treatment of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia with blinatumomab in a real-world setting.
He outlines the trial design, results and toxicity profile.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
Related Videos
Long-term follow-up of low-intensity chemotherapy with combination therapy for r...
Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA
22 Dec 2020
Five year update of ECHELON-1 for classical Hodgkin lymphoma
Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil
8 Dec 2020
Phase II data from the KarMMa trial for relapsed/refractory multiple myeloma
Dr Nikhil Munshi - Dana Farber Cancer Institute, Boston, USA
16 Jun 2020
OPTIC: A dose-ranging study of 3 starting doses of ponatinib for chronic-phase c...
Prof Jorge Cortes - Augusta University, Augusta, USA
13 Jun 2020
Investigating KRd versus KTd in NDMM patients with high-risk cytogenetics
Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria
13 Jun 2020
CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple...
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
13 Jun 2020
Teclistamab for patients with heavily pretreated relapsed or refractory multiple...
Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA
1 Jun 2020
Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma pati...
Dr Charlotte Pawlyn - Royal Marsden Hospital, London, UK
25 Sep 2019
First results of the GMMG-CONCEPT trial for multiple myeloma
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
25 Sep 2019
